Regulated Information

Financial Publications

 
Sartorius Stedim Biotech Group 1st Half-Year Report Jan. to Jun. 2010
More

Capital Stock | Total Number of Voting Rights and Shares

Capital stock:

10,369,626.68 Euro

Number of shares:

16,999,388

Voting rights:

19,019,196

More

Share Repurchase

05-28-2010 

Disclosure of trading in own shares

More

Further Announcements

07-06-2010 

Bilan semestriel du contrat de liquidité contracte avec la societé de bourse Gilbert Dupont (available only in french)

More Announcements

Press Releases

07-26-2010 
First-half figures for 2010: Further growth and increase in profit
06-15-2010 
ATMI and Sartorius Stedim Biotech Extend Global Supply and Marketing Alliance
More Press Releases

Presentations

Jul 27, 2010

Analysts´ Conference (SFAF), Paris

Jul 26, 2010

Conference Call | Web Presentation on First-Half Figures for 2010

Conference Call, July 26, 2010
Dr. Joachim Kreuzburg, Chairman of the Board and CEO of Sartorius Stedim Biotech S.A.:
audio (.mp3, 6.5 MB)
audio (.wmv, with presentation, 8.0 MB)

More Presentations